Clinical Trial Update: Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol's effects on reward- and stress-related neurocognitive processes in individuals with opioid use disorder has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid-use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-10-05